UIC to lead $14.6 million, multi-center COPD research project

The University of Illinois at Chicago will lead a $14.6 million, multi-center research project to determine which of two drugs — azithromycin, an antibiotic, or roflumilast, an anti-inflammatory medication — is the most effective at treating chronic obstructive pulmonary disease, which is also known as COPD.
Source: News Medical, https://www.news-medical.net/